Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men.
Adolescent
Adult
Androgens
/ adverse effects
Cross-Sectional Studies
Feasibility Studies
Female
Fertility Preservation
Gender Dysphoria
/ psychology
Gender Identity
Gene Expression Regulation, Developmental
Humans
In Vitro Oocyte Maturation Techniques
Male
Ovarian Follicle
/ drug effects
Pregnancy
Sex Reassignment Procedures
/ adverse effects
Sperm Injections, Intracytoplasmic
Testosterone
/ adverse effects
Time Factors
Transgender Persons
/ psychology
Transsexualism
/ physiopathology
Treatment Outcome
Young Adult
Fertility preservation
in vitro oocyte maturation
ovarian tissue oocyte
transgenderism
Journal
Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
02
12
2020
revised:
05
03
2021
accepted:
05
03
2021
pubmed:
10
4
2021
medline:
9
11
2021
entrez:
9
4
2021
Statut:
ppublish
Résumé
To study the feasibility of in vitro maturation of ovarian tissue oocytes for fertility preservation in transgender men on testosterone treatment. Cross-sectional study SETTING: University hospital PATIENT(S): Eighty-three transgender men enrolled from November 2015 to January 2019 INTERVENTION(S): In vitro maturation of cumulus-oocyte complexes (COCs) harvested at the time of gender confirmation surgery, and fertilization through intracytoplasmic sperm injection. In vitro maturation, fertilization, and blastulation rates; comparison of morphokinetics with vitrified-warmed oocytes; and analysis of the genetic profiles of embryos. association between serum hormone levels; COCs' morphologic characteristics, and vitrification rate. All participants were on testosterone treatment for a median of 83 (64[Quartile 1]; 113.2[Quartile 2]) weeks. A total of 1,903 COCs (mean per participant, 23 ± 15.8) were collected. The in vitro maturation rate was 23.8%, vitrification rate was 21.5%, and survival rate after warming was 72.6% (n = 151). Intracytoplasmic sperm injection was performed in 139 oocytes. The rate of normal fertilized oocytes was 34.5%, and 25 (52.1%) embryos reached day 3. One blastocyst was achieved on day 5. Aberrant cleavage patterns and early embryo arrest were observed in 22 (45.8%) and 44 (91.7%) zygotes, respectively. Compared with vitrified-warmed donor oocytes, a delay was observed in pronuclei disappearance, t2 (time to reach 2 cell stage) timings, and CC1 (the duration of the 1st cell cycle) and SS3 (synchronization of cleavage pattern (calculated as t8-t5) time intervals. A normal genetic pattern was seen in 42% embryos. The proportion of vitrified oocytes was negatively associated with progesterone (odds ratio, 0.76) and positively associated with antimüllerian hormone serum levels (odds ratio, 1.23). The highest vitrification rate was achieved by the morphologic characteristic 344 at day 0 and by 433 at day 2. Ovarian tissue oocytes matured in vitro show low developmental capacity in transgender men, when collected under testosterone treatment.
Identifiants
pubmed: 33832736
pii: S0015-0282(21)00214-4
doi: 10.1016/j.fertnstert.2021.03.009
pii:
doi:
Substances chimiques
Androgens
0
Testosterone
3XMK78S47O
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1068-1076Informations de copyright
Copyright © 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.